CEACAM5 and colorectal cancer: Likewise, carcinoembryonic antigen (CEA) has also been used as a target in colorectal cancer; however, the administration of T cells expressing a CEA-specific T cell receptor (TCR) to patients induced severe colitis targeting intestinal CEA, thus limiting its potential [6].